Arkesh Mehta
OncoBindi Therapeutics, USA
Biography
Arkesh Mehta serves as Chief Executive Officer of OncoBindi Therapeutics and a member of the company’s Board of Directors, bringing more than 30 years of experience in the biopharmaceutical industry to the company. He joined OncoBindi in 2016 as the company’s Founding Chief Executive Officer. He joined OncoBindi from Chikujee Therapeutics, where he served as Chairman & Chief Executive Officer, since 2014, prior to its acquisition by a group of investors from Germinate 360. Prior to joining Chikujee Therapeutics, he held senior management positions at Avanti Nano Sciences, BPI Technologies, and Avanti Therapeutics. In addition, he was a key member of the strategic leadership committees for Avanti Therapeutics and it's North American and worldwide partnerships. Prior to joining Avanti Therapeutics, he was the first CTO of the Biotechnology Industry Organization. He has held leadership program management positions at Office of R&D US EPA, Office of the Commissioner US FDA. His academic appointments include the head of Molecular biology section at Virginia State University and Associate Professor of Research at Cornell University. He received a PhD. in Microbiology from M.S. University and post-doctoral training from University of Mississippi Medical Center in Jackson, Mississippi.
Abstract
Abstract : Aayush BioSphere: Clinical outcome focused platform for precision therapeutic development